Learn about DUPIXENT® (dupilumab), the first and only FDA-approved biologic treatment for adult & pediatric patients aged 6+ years and older with allergic fungal rhinosinusitis (AFRS) who have a history of sino-nasal surgery. Serious adverse reactions can occur. Please see Important Safety Information and full Prescribing Information on website.